T/GDACM 0111-2022 Chinese medicine technical operation specification: Self-blood acupoint injection for treatment of bronchial asthma

Scope

Main technical content: Blood is the essence substance in living organisms. There are records of drinking deer blood to nourish the body in ancient times. Traditional Chinese medicine uses one's own blood as a medicine in clinical practice, which was first recorded in Li Shizhen's "Compendium of Materia Medica" in the Ming Dynasty. The first application of autologous blood injection therapy was in the former Soviet Union, mainly used to treat hemoptysis in patients with pulmonary tuberculosis. It was introduced to China in the 1950s, and a detailed introduction was given in the "Russian Translation Collection" in 1956. In the mid-to-late 1960s, Professor Jin Rui of Guangzhou University of Chinese Medicine pioneered the application of autologous blood in acupoint injection, naming it "Meridian Blood Injection Therapy", and treated diseases of various systems, including bronchial asthma, with good therapeutic effects. While observing clinical applications, Professor Jin Rui also conducted animal experimental research and achieved good results, publishing an article in "New Traditional Chinese Medicine" in 1973. Autologous acupoint injection therapy is a comprehensive innovation of traditional Chinese medicine based on the theory of meridians and collaterals, acupuncture techniques, acupoint injection operation, and the effects of blood. The therapy mainly uses blood to stimulate and regulate meridian and acupoints to achieve a series of methods of treating diseases and strengthening the body. It has certain therapeutic effects on allergic diseases such as bronchial asthma, allergic rhinitis, and chronic urticaria, as well as some internal medicine miscellaneous diseases such as anemia and acne. Especially for bronchial asthma.

Development Information

Related Standards